American multinational healthcare company, Abbott, has partnered with AfriMedical Manufacturing and Supplies Limited to boost local production of diagnostic products in Nigeria.
They stated that the collaboration was designed to improve access to quality diagnostic tools, reduce dependence on imports, and support Nigeria’s efforts to build a more resilient healthcare supply chain.
The partnership brought together Abbott, the Federal Ministry of Health and Social Welfare, the Presidential Initiative for Unlocking the Health Value Chain, and Afrimedical, a division of Mikano International Limited.
The collaboration will see Abbott localising production of its most advanced rapid diagnostic technology in Nigeria, including Abbott’s integrated Determine Antenatal Care (ANC) Panel, the first and only World Health Organisation prequalified diagnostic test that supports the triple elimination of HIV, syphilis, and hepatitis B virus.
The local production move by Abbott is also in line with the Federal Government’s target of increasing local manufacturing of pharmaceuticals and vaccines in Nigeria to at least 70% by 2030.
